Skip to search formSkip to main contentSkip to account menu

Hyperparathyroidism, Secondary

Known as: HYPERPARATHYROIDISM SECONDARY, Secondary hyperparathyroidism, Hyperparathyroidism, Secondary [Disease/Finding] 
Abnormally elevated PARATHYROID HORMONE secretion as a response to HYPOCALCEMIA. It is caused by chronic KIDNEY FAILURE or other abnormalities in the… 
National Institutes of Health

Related topics

Related topics

15 relations
Endocrine System DiseasesEndocrine systemHead and neck structureIn Blood

Broader (1)

Hyperparathyroidism

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2007
Highly Cited
2007
Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype.
CONTEXT Patients with elevated PTH and consistently normal serum calcium levels, in whom secondary causes of hyperparathyroidism… 
Highly Cited
2004
Highly Cited
2004
Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency.
BACKGROUND Fibroblast growth factor 23 (FGF-23) is a recently identified polypeptide that promotes renal phosphate excretion and… 
Highly Cited
2003
Highly Cited
2003
PTH excess may promote weight gain by impeding catecholamine-induced lipolysis-implications for the impact of calcium, vitamin D, and alcohol on body weight.
Review
2000
Review
2000
Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management.
Highly Cited
1997
Highly Cited
1997
Population-based screening for primary hyperparathyroidism with serum calcium and parathyroid hormone values in menopausal women.
Highly Cited
1996
Highly Cited
1996
Healthy elderly French women living at home have secondary hyperparathyroidism and high bone turnover in winter. EPIDOS Study Group.
It was recently demonstrated that calcium and vitamin D supplements were capable of decreasing the incidence of hip fractures in… 
Review
1994
Review
1994
Pathogenesis of secondary hyperparathyroidism.
Highly Cited
1994
Highly Cited
1994
Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy.
Intermittent calcitriol therapy is commonly used to treat secondary hyperparathyroidism in patients undergoing regular dialysis… 
Highly Cited
1984
Highly Cited
1984
Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.
Current evidence suggests that administration of 1,25(OH)2D3 to patients with chronic renal insufficiency results in suppression… 
Highly Cited
1973
Highly Cited
1973
Evidence for secondary hyperparathyroidism in idiopathic hypercalciuria.
Circulating levels of immunoreactive parathyroid hormone (PTH) were measured in 40 patients with idiopathic hypercalciuria (IH… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)